Symbol="TRVN"
AssetType="Common Stock"
Name="Trevena Inc"
Description="Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of new drugs for patients affected by disorders of the central nervous system. The company is headquartered in Chesterbrook, Pennsylvania."
CIK="1429560"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="9611000"
EBITDA="-49689000"
PERatio="None"
PEGRatio="0"
BookValue="2.014"
DividendPerShare="0"
DividendYield="0"
EPS="-6.06"
RevenuePerShareTTM="-0.059"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.609"
ReturnOnEquityTTM="-1.515"
RevenueTTM="-432000"
GrossProfitTTM="-3436000"
DilutedEPSTTM="-6.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="5.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="106.03"
PriceToBookRatio="0.569"
EVToRevenue="18.8"
EVToEBITDA="0.132"
Beta="1.914"
num_52WeekHigh="6.25"
num_52WeekLow="0.58"
num_50DayMovingAverage="0.948"
num_200DayMovingAverage="1.475"
SharesOutstanding="10969000"
DividendDate="None"
ExDividendDate="None"
symbol="TRVN"
open="0.86"
high="0.93"
low="0.85"
price="0.91"
volume="98563.00"
latest_trading_day="2023-08-18"
previous_close="0.88"
change="0.03"
change_percent="3.2869%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="40"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="1843742"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.38"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="171"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0005.jpeg"
image_negative_thumbnail_id_2="150"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0026.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="558"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_positive_thumbnail_id_1="672"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_positive_thumbnail_id_2="607"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
